Literature DB >> 22081675

Structural brain abnormalities in patients with Parkinson disease: a comparative voxel-based analysis using T1-weighted MR imaging and magnetization transfer imaging.

K Morgen1, G Sammer, L Weber, B Aslan, C Müller, G F Bachmann, D Sandmann, M Oechsner, D Vaitl, M Kaps, I Reuter.   

Abstract

BACKGROUND AND
PURPOSE: In PD, tissue damage occurs in specific cortical and subcortical regions. Conventional MR images have only limited capacity to depict these structural changes. The purpose of the current study was to investigate whether voxel-based MT imaging could indicate structural abnormalities beyond atrophy measurable with T1-weighted MR imaging.
MATERIALS AND METHODS: Thirty-six patients with PD without dementia (9 in H&Y stage 1, thirteen in H&Y 2, eleven in H&Y 3, three in H&Y 4) and 23 age-matched control subjects were studied with T1-weighted MR imaging and MT imaging. Voxel-based analyses of T1-weighted MR imaging was performed to investigate brain atrophy, while MT imaging was used to study abnormalities within existing tissue. Modulated GM and WM probability maps, sensitive to volume, and nonmodulated maps, indicative of tissue density, were obtained from T1-weighted MR imaging. Effects seen on MTR images, but absent on density maps, were attributed to damage of existing tissue.
RESULTS: Contrary to T1-weighted MR imaging, MT imaging was sensitive to the progression of brain pathology of the neocortex and paraventricular WM. MTR images and T1-based volume images, but not density images, showed a progression of disease in the olfactory cortex, indicating the occurrence of atrophy as well as damage to existing tissue in this region. MTR images revealed bilateral damage to the SN, while T1-weighted MR imaging only showed left-sided abnormalities.
CONCLUSIONS: The findings suggest that voxel-based MT imaging permits a whole-brain unbiased investigation of CNS structural integrity in PD and may be a valuable tool for identifying structural damage occurring without or before measurable atrophy.

Entities:  

Mesh:

Year:  2011        PMID: 22081675      PMCID: PMC7964402          DOI: 10.3174/ajnr.A2837

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

3.  Imaging amyloid deposition in Lewy body diseases.

Authors:  S N Gomperts; D M Rentz; E Moran; J A Becker; J J Locascio; W E Klunk; C A Mathis; D R Elmaleh; T Shoup; A J Fischman; B T Hyman; J H Growdon; K A Johnson
Journal:  Neurology       Date:  2008-09-16       Impact factor: 9.910

4.  Magnetization transfer changes of grey and white matter in Parkinson's disease.

Authors:  N Tambasco; G P Pelliccioli; P Chiarini; G E Montanari; F Leone; M L Mancini; M Paciaroni; V Gallai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

5.  A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry.

Authors:  Mona K Beyer; Carmen C Janvin; Jan P Larsen; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 7.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

8.  Cognitive status correlates with neuropathologic stage in Parkinson disease.

Authors:  H Braak; U Rüb; E N H Jansen Steur; K Del Tredici; R A I de Vos
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

9.  Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

Authors:  Pekka Jokinen; Anna Brück; Sargo Aalto; Sarita Forsback; Riitta Parkkola; Juha O Rinne
Journal:  Parkinsonism Relat Disord       Date:  2008-04-22       Impact factor: 4.891

10.  Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study.

Authors:  L Ramió-Torrentà; J Sastre-Garriga; G T Ingle; G R Davies; V Ameen; D H Miller; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

View more
  9 in total

Review 1.  Post-transcriptional regulatory elements and spatiotemporal specification of neocortical stem cells and projection neurons.

Authors:  E M DeBoer; M L Kraushar; R P Hart; M-R Rasin
Journal:  Neuroscience       Date:  2013-05-30       Impact factor: 3.590

2.  Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results.

Authors:  S Haller; S Badoud; D Nguyen; V Garibotto; K O Lovblad; P R Burkhard
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-31       Impact factor: 3.825

3.  Methodological improvements in voxel-based analysis of diffusion tensor images: applications to study the impact of apolipoprotein E on white matter integrity.

Authors:  Shawn M Newlander; Alan Chu; Usha S Sinha; Po H Lu; George Bartzokis
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

Review 4.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

5.  Chemical exchange saturation transfer MR imaging of Parkinson's disease at 3 Tesla.

Authors:  Chunmei Li; Shuai Peng; Rui Wang; Haibo Chen; Wen Su; Xuna Zhao; Jinyuan Zhou; Min Chen
Journal:  Eur Radiol       Date:  2014-07-20       Impact factor: 5.315

6.  Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.

Authors:  Paula Trujillo; Paul E Summers; Alex K Smith; Seth A Smith; Luca T Mainardi; Sergio Cerutti; Daniel O Claassen; Antonella Costa
Journal:  Neuroradiology       Date:  2017-10-06       Impact factor: 2.804

7.  Magnetic Resonance Imaging (MRI) in Parkinson's Disease.

Authors:  Paul J Tuite; Silvia Mangia; Shalom Michaeli
Journal:  J Alzheimers Dis Parkinsonism       Date:  2013-03-25

Review 8.  Structural Imaging and Parkinson's Disease: Moving Toward Quantitative Markers of Disease Progression.

Authors:  N W Sterling; M M Lewis; G Du; X Huang
Journal:  J Parkinsons Dis       Date:  2016-05-27       Impact factor: 5.568

9.  Changes of Amide Proton Transfer Imaging in Multiple System Atrophy Parkinsonism Type.

Authors:  Shuhua Li; Piu Chan; Chunmei Li; Haibo Chen; Min Chen; Wen Su; Kai Li; Na Lu; Lu Yu; Defa Chu; Pu-Yeh Wu
Journal:  Front Aging Neurosci       Date:  2020-09-30       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.